Covetrus Inc. (Nasdaq: CVET), the Portland-based animal health technology and services company, posted a smaller fourth-quarter loss in 2021 than a year ago, and forecast higher sales growth for 2022.

The company late Thursday reported a before-tax loss of $10 million, or 2 cents per share, for the three months ended Dec. 31, 2021. That was down from a loss of $16 million, or 4 cents per share, for the same period in 2020.

Net sales for the fourth quarter of 2021 were $1.12 billion, unchanged compared to the year-ago quarter. Read more